Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine

dc.creatorMagalh??es, Elza
dc.creatorMenezes, Carla
dc.creatorCardeal, Mauricio
dc.creatorMelo, Ailton de Souza
dc.date.accessioned2019-05-22T15:22:28Z
dc.date.available2019-05-22T15:22:28Z
dc.date.issued2010
dc.identifier0303-8467
dc.identifierhttp://www.repositorio.ufba.br/ri/handle/ri/5767
dc.identifierv. 112, n. 6
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/2700947
dc.description.abstract
dc.languageen
dc.sourceDOI: 10.1016/j.clineuro.2010.02.004
dc.subjectChronic migraine
dc.subjectAmitriptyline
dc.subjectBotulinum toxin
dc.titleBotulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine
dc.typeArtigo de Peri??dico


Este ítem pertenece a la siguiente institución